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Midterm Outcomes of Secondary Procedures Following Endovascular
Aneurysm Repair: A Prospective Analysis
ManishMehta, Yaron Sternbach, John B. Taggert, Paul B. Kreienberg, Sean
P. Roddy, Philip S. K. Paty, R. Clement Darling III, Benjamin B. Chang,
Dhiraj M. Shah, and Kathleen J. Ozsvath, From The Vascular Group
PLLC. Albany, NY
Background: We evaluated the outcomes of secondary procedures
after endovascular aneurysm repair (EVAR).
Methods: From 2002 to 2008, 1450 patients underwent EVAR and
were evaluated by computed tomography angiography (CTA) every 6 to 12
months. Patients with type I and III endoleaks, unexplained endotension,
limb occlusion, stent graft migration with and without type I endoleak, and
aneurysm rupture underwent secondary interventions. Type II endoleaks at
6 months without a decrease in the aneurysm sac underwent translumbar
embolization. Data were prospectively collected.
Results: After 1450 EVAR procedures, 1362 elective (94%) and 88
emergency (6%), 259 patients (17.9%) required additional procedures dur-
ing a mean follow-up of 32 months (range, 1-84 months). Of these, 229
(15.8%) required secondary procedures consisting of 200 endovascular
(87%) and 29 open surgical procedures (13%; Table). Of 29 patients with
aneurysm rupture, 22 (76%) were considered lost to follow-up after the
initial EVAR. An additional 30 patients (2.1%) required tertiary procedures,
including repeat translumbar embolization in 12 (0.8%), repeat proximal
stent graft extension for migration in 11 (0.8%), and elective open surgical
repair in 7 (0.5%). The overall mortality of these second and third proce-
dures was 3.9% and was highest in the aneurysm rupture group at 15% (4 of
29 patients; Table).
Conclusions: Our midterm experience indicates that 18% of patients
require additional secondary and tertiary procedures. Almost all of these
patients can be managed by endovascular means, with acceptable overall
mortality of 3.9%. Most type I endoleaks can be successfully treated by
translumbar embolization. Most patients with delayed aneurysm rupture
after EVAR can be successfully managed by endovascular or open surgical
repair.
Table. Midterm outcomes of secondary procedures after
endovascular aneurysm repair
Indication No. (%) Secondary procedures No. (%) Death No. (%)
Endoleak
Type I 39 (2.7) Proximal SG extension 14 (36) 2 (5)
TL embo 17 (44)
Spontaneous seal 6 (15)
Open surgical repair 2 (5)
Type II 104 (7.1) TL embo 98 (94) 2 (2)
Transfemoral embo 6 (6)
Type III 3 (0.2) SG extension 3 (100) -
Endotension 12 (0.8) SG relining 8 (67) -
Open surgical repair 2 (17)
No treatment 2 (17)
Limb thrombosis 14 (1) Fem-fem bypass 7 (50) 1 (7)
SG thrombectomy 5 (36)
No treatment 2 (14)
Migration 38 (2.6) SG extension 28 (74) 1 (3)
AUI 10 (36)
Rupture 29 (2.0) Open surgical repair 15 (52) 4 (15)
EVAR 13 (45)
Refused treatment 1 (3)
AUI, aortouniiliac, EVAR, endovascular aneurysm repair; SG, stent graft;
TL, translumbar.
Risk Factors for Late Mortality Following Endovascular Thoracic
Aneurysm Repair
Jayer Chung, Karthik Kasirajan, Ravi Veeraswamy, Matthew Corriere,
Thomas Dodson, Ross Milner, Atef Salam, and Elliot L. Chaikof, From
Emory University. Atlanta, Ga
Background: This study identified risk factors for late mortality after
thoracic endovascular aortic repair (TEVAR).
Methods: A retrospective analysis of a prospectively maintained data-
base of consecutive TEVAR was conducted. Thirty-day and late survival was
determined by medical record review, telephone contact, or query of the
Social Security Death Index. Late mortality was assessed with respect to
patient characteristics at the time of initial treatment (ages, gender, pulmo-
nary, cardiac and renal disease, hypertension, hyperlipidemia, diabetes,
medication) preoperative laboratory values (albumin, hemoglobin, whiteblood cell [WBC] count, platelet count, creatinine), pathology (aneurysm
type, diameter), clinical presentation (symptomatic, rupture), and treatment
adjuncts (debranching). Variables significant by univariate analysis were
entered into a multivariate Cox regression model to ascertain independent
predictors of mortality.
Results: From 1998 and 2009, 252 patients (149men; median age, 70
years) underwent TEVAR. Indications were degenerative thoracic aortic
aneurysm (TAA) in 143, type B dissection in 62, mycotic aneurysm in 13,
traumatic disruption in 12, penetrating ulcer/intramural hematoma in 10,
anastomotic pseudoaneurysm in 4, or other pathology in 8. The 30-day
mortality was 9.5%, with stroke or spinal cord injury in 5.6%. Mean  SD
follow-up was 22  22 months, with a Kaplan-Meier mean survival of 53
months. Predominant causes of late death were cardiac disease, malignancy,
and chronic obstructive pulmonary disease (COPD). Predictors of late death
by univariate analysis included age (P  .01), cardiac arrhythmia (P  .03),
COPD (P .05), hyperlipidemia (P .03), statin use (P .02), aneurysm
diameter (P  .01), rupture, and elevated creatinine (P  01). Multivariate
analysis revealed that rupture (hazard ratio [HR] 3.1; 95% confidence
interval [CI], 1.02-9.44; P  03), debranching (HR, 2.20; 95% CI, 1.09-
4.24; P .03), preoperativeWBC count (HR, 1.23; 95%CI 1.09-1.39; P
.001), and aneurysm diameter (HR, 1.02; 95% CI 1.01-1.03; P .04) were
independent predictors of late mortality. Subgroup analysis of patients
undergoing elective TEVAR for asymptomatic, nonruptured TAA demon-
strated that debranching (HR, 2.47; 95% CI, 1.13-5.39; P  .02), WBC
count (HR, 1.19; 95% CI, 1.01-1.40; P  .04), and aneurysm diameter
(HR, 1.03; 95% CI 1.01-1.05; P .01) remain independently predictive of
late mortality (Fig 1).
Conclusions: Despite adequate initial repair, long-term survival after
TEVAR remains compromised. Concurrent debranching, preoperative
WBC count, and aneurysm diameter independently predict late mortality
irrespective of clinical presentation and may assist in risk stratification.
Defining the Burden of Indigent Vascular Care: The Impact of Socio-
economic Factors on Lower Extremity Revascularization
Christopher A. Durham, Dorian J. deFreitas, Mark M. Manwaring, Carolyn
Mohr, Charles S. Powell, William M. Bogey, Frank M. Parker, and Michael
C. Stoner, From East Carolina University. Greenville, NC
Background:Within the context of health care system reform, the cost
efficacy of lower extremity revascularization remains a timely topic. The
effect of an individual patient’s socioeconomic status represents an under-
studied aspect of vascular care, especially with respect to longitudinal costs
and outcomes. The purpose of this study was to examine the relationship
between socioeconomic status and these factors.
Methods: A retrospective femoropopliteal revascularization database,
which included socioeconomic factors (household income, education level,
and payor status), in addition to standard demographic, clinical, anatomic,
and procedural variables, was analyzed during a 3-year period. Patients were
stratified by income level (low income [LI] 200% federal poverty level
[$42,400 for a household of 4], and higher income [HI] 200% federal
poverty level) and revascularization technique (open vs endovascular), and
analyzed for the end points of primary assisted patency, amortized cost per
day of patency, and limb salvage. Data were analyzed with univariate and
multivariate techniques.
Results: A total of 187 patients were identified with complete data for
analysis, 145 in the LI and 41 in theHI cohorts. LI patients differed fromHI
Fig 1. Survival after thoracic endovascular aortic repair is shown
for (A) the study population stratified by white blood cell (WBC)
count 103 cells/mL and 103 cells/mL (P  .01) and (B) for
the subgroup of asymptomatic nonruptured thoracic aneurysms
stratified by WBC count (P  .01)patients by mean age (66.2 1.0 vs 61.8 1.5 years, P .04), high school
graduate rate (51.4% vs 85.4%, P  .001), presence of tissue loss (30.1% vs
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statin use (45.8% vs 75.6%, P  .001). There were no differences with
respect to other comorbidities, including smoking status, presence of diabe-
tes, renal insufficiency, anatomic factors, or open vs endovascular treatment.
Ninety-seven patients underwent endovascular revascularization. The fol-
lowing outcomes were noted in the endovascular subset of LI and HI
patients, respectively: primary-assisted patency was 71% vs 66% (P  NS),
and 12-month cost per day of patency was $166.30  $77.40 vs $22.45 
$12.45 (P  .05). Ninety-eight patients underwent open revascularization,
with the following outcomes in LI and HI patients respectively: primary
assisted patency was 78% vs 86% (P  NS), and the 12-month cost per day
of patency was $319.43  $225.44 vs $40.47  $4.63 (P  .07). Ampu-
tation was eventually required in 19 of the 77 patients with critical limb
ischemia. Multivariate analysis demonstrated that HI was protective against
limb loss (odds ratio, 0.06; 95% confidence interval, 0.01-0.51; P  .001).
Conclusion: In patients undergoing femoropopliteal revasculariza-
tion, income level correlates with advanced disease state presentation, ad-
vanced age (possibly a proxy for delayed presentation), and lack of statin use.
Although the primary-assisted patency rate is not affected by income status,
LI patients demonstrate an increased cost per day of patency and inferior
limb salvage compared with HI patients. To our knowledge, these data are
the first to establish a relationship between income and metrics of lower
extremity revascularization success and demonstrate the financial and clinical
burden associated with caring for these patients.
Prospective Randomized Trial of Routine vs Selective Shunting in
Carotid Endarterectomy Based on Stump Pressure
Ali F. AbuRahma, Patrick A. Stone, StephenM.Hass, L. Scott Dean, Joseph
Habib, Tammi Keiffer, andMary Emmett, From the Robert C. Byrd Health
Sciences Center of West Virginia University. Charleston, WV
Background: The use of shunting in carotid endarterectomy (CEA) is
controversial. Only a few randomized trials have compared routine vs
selective shunting; however, none were based on stump pressure (SP). To
our knowledge, this is the first randomized trial to compare the results of
routine (RS) vs selective shunting (SS) based on SP.
Methods: The study randomized 200 CEA patients under general
anesthesia into RS (n 98) and SS (n 102), where shunting was used only
if systolic SP was40mmHg (SSP). All patients had immediate and 30-day
postoperative duplex ultrasound imaging. Analysis was done based on
intention to treat.
Results: Shunting was used in 29 of 102 SS patients (28%). Clinical/
demographic characteristics were comparable in both groups. Indications
for CEAwere also similar (42% symptomatic for RS vs 47% for SS, P .458).
The mean internal carotid artery diameter was also comparable (5.5 vs 5.5,
P  .685). The mean preoperative ipsilateral and contralateral stenosis was
76% and 38% for RS (P  .268) vs 78% and 40% for SS (P  .528),
respectively. The mean preoperative ipsilateral and contralateral stenoses
were 79% and 56% in the shunted (P  .634) vs 78% and 34% in the
nonshunted subgroup of SS patients P .002), respectively. The mean SSP
was 55.9 in RS vs 56.2 mm Hg for SS (P  .915). The mean SSP in the
shunted vs non-shunted subgroup of SS was 33 vs 65 mmHg (P  .0001).
Mean clamp time in the nonshunted SS subgroup was 32 minutes. Mean
shunt time was 35 minutes in RS vs 33 minutes in SS (P  .354). Mean
operative time was 113 minutes for RS and 109 minutes for SS (P  .252)
and 111 minutes in shunted and 108 minutes in the nonshunted subgroup
(P  .586). Mean arteriotomy length was 4.4 cm for RS and 4.2 cm for SS
(P  .213). Perioperative stroke rate was 0% for RS vs 2% for SS, consisting
of one major and one minor stroke (neither patient was shunted; P .498).
No perioperative deaths occurred. The combined perioperative transient
ischemic attack and stroke rates were 2% in RS vs 2.9% in SS (P  1). The
overall perioperative complication rates were 8.3% in RS (2 transient isch-
emic attacks, 3 bleeding, and 1 myocardial infarction, and 1 asymptomatic
carotid thrombosis) vs 7.8% in SS (2 strokes, 1 transient ischemic attack, 3
bleeding, 1 myocardial infarction, and 1 congestive heart failure; P .917).
Conclusions: Perioperative stroke/overall complication rates were
somewhat similar for RS and SS based on SSP of 40 mm Hg.
Maximal Venous Outflow Velocity: A Novel Technique for Detecting
Iliocaval Occlusive Disease
T. Matthew Jones, David C. Cassada, Oscar H. Grandas, Scott L. Stevens,
Michael B. Freeman, and Mitchell H. Goldman, From the University of
Tennessee Medical Center at Knoxville. Knoxville, Tenn
Background: Compression of the left iliac vein by the overlying right
iliac artery (May-Thurner Syndrome [MTS]) can cause left leg swelling due
to outflow obstruction, increasing the risk for deep vein thrombosis. Dis-
cerning pathologic anatomy from normal iliocaval anatomy can be challeng-
ing, as planar imaging provides anatomic rather than functional information.
Traditional duplex ultrasound (DU) interrogation of the leg provides data
limited to only the infrainguinal venous system. Our hypothesis is that
DU-derived maximal venous outflow velocity (MVOV) can be a usefulscreening tool as an adjunct to lower extremity DU to screen for patients
with iliocaval obstruction.
Methods: MVOV studies of 14 patients with unilateral leg swelling
from 2000 to 2009were compared with a control group of 30 asymptomatic
volunteers. Right and left legs of the test group and symptomatic and
asymptomatic legs were compared with each other and with controls using
the t test. A ratio of symptomatic to asymptomatic extremities was compared
to left over right in the controls to generate an index compatible with
pathologic venous impedance. The same parameters were also compared
after endovenous stenting for positive venographic findings in patients with
MTS.
Results: Symptomatic extremities had reduced absolute MVOVs (P
.021) compared with the contralateral extremity. In four patients undergo-
ing endovascular stenting for MTS, a significant increase in MVOV of the
treated leg was observed (P  .012), and the post-treatment MVOV
measurements in the left and right legs were not significantly different (P 
.213). On review, we found that a left-to-right MVOV index of 1.06
correlated with positive angiographic findings and success of treatment (P
.0434). In this same group, computed tomography with venous contrast
predicted a positive venographic finding in 60% of the patients (3 of 5).
Conclusions: Because most patients with unilateral leg swelling un-
dergo routine DU imaging to evaluate for deep vein thrombosis, MVOV
studies can be obtained without added risk, exposure, and little technical
cost. MVOV and a calculated index of 1.06 seems to be predictive of
success of intervention, even when CT interpretation suggested otherwise.
Thoracic Endovascular Aortic Repair Does Not Alter the Natural
History of Traumatic Aortic Disruption
Jennifer L. Lang, Stephen T. Smith, Joseph P.Minei, J. GregoryModrall, G.
Patrick Clagett, and Rawson J. Valentine, From the University of Texas
Southwestern Medical Center. Dallas, Tex
Background: Thoracic endovascular aortic repair (TEVAR) is an ac-
cepted treatment option for traumatic aortic disruption (TAD) despite little
data on long-term outcome. We hypothesized that early TEVAR in patients
with TAD would reduce deaths from aortic rupture in patients who arrive
alive at the hospital.
Fig 1. Maximal venous outflow velocity (MMOV) changes after
intervention.
Fig 2.Methods:We reviewed the medical records of 112 patients with TAD
treated at a level I trauma center during a 10-year period. Medical examiner
